27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- Phibro Animal Health Corp (NASDAQ:PAHC) posted Q3 FY22 sales of $239.6 million, +13% Y/Y, beating the consensus of $226.26 million.
- Adjusted EPS decreased 3% to $0.33, missing the consensus of $0.35.
- The gross margin decreased 280 basis points to 29.9%. Adjusted EBITDA of $28.0 million, comparable to the prior year.
- "Our fiscal year-to-date net sales reflect year-over-year growth of 12%, driven by double-digit sales growth across all segments - a 10% improvement in our core Animal Health segment and net sales growth of 16% and 12% in our Mineral Nutrition and Performance Products segments, respectively," said Jack Bendheim, Phibro's Chairman, President, and CEO.
- Guidance: Phibro raised its FY22 sales to $930 million – $950 million (consensus $907.54 million) from $890 million – $920 million.
- The company says that revised guidance assumes that supply chain and labor challenges will persist for the remainder of our fiscal year.
- It reaffirms adjusted EPS guidance of $1.30 - $1.39, compared to the consensus of $1.36.
- The company expects adjusted EBITDA of approximately $110.0 – $114.0 million.
- Price Action: PAHC shares closed at $19.87 on Wednesday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!